15Dec
Life Sciences Dealmaking Symposium: Powering through the Pandemic: Trends in Early-Stage Investment
The pursuit of progress during these unprecedented times has led to a surge in life sciences investment and funding for early stage companies. Investors are on the lookout for the next big innovation while also navigating new ways of sourcing and managing portfolio companies. Our panel of experienced early-stage investors discussed the top trends in this push for advancement, including sectors attracting the most dollars in today’s challenging business landscape, key issues that early stage...
By:
McDermott Will & Emery
Related
On Thursday, January 30, members of Verrill’s Labor & Employment Group and Employee Benefits & Exec...
Read More >
Following the enactment of the Competition Amendment Act during 2019 and the subsequent promulgation...
Read More >
In the past few months, we have seen significant changes to the laws governing employee benefits, fr...
Read More >
Leveraged buyout high yield bond and leveraged loan issuance fell in Q3 2020 as a lack of buyout dea...
Read More >
The European Commission is expected to issue a White Paper on an Instrument on Foreign Subsidies on ...
Read More >
Seyfarth Synopsis: The Michigan Occupational Safety and Health Administration has amended its constr...
Read More >